Engeye Health Clinic in Uganda Seeks Aid for Ugandan Seven-Year-Old Girl with Cancer

Posted by: Doctor Medical  :  Category: Health

Albany, NY, January 27, 2012 –(PR.com)– On July 12th, the Engeye Health Clinic treated Noeline, a seven-year old girl from one of the many small villages served by Engeye in southern Uganda. Shy, feverish, and clearly ill upon her arrival, Noeline was diagnosed with an extremely serious and life-threatening condition which requires urgent medical care that extends beyond the Engeye Clinic’s capabilities. Nonetheless, the Engeye team is committed to helping her receive this life-saving care as soon as possible, and they need help to do so.

Like other rural Ugandans, Noeline lives a simple life, helps fetch water for her family, assists with farming and, when funds are available, attends the local primary school. In February, however, she began to develop an unusual tissue growth protruding from her vagina. Over time, Noeline’s condition worsened, and her mother took her to the nearby health center where a biopsy was performed. The biopsy revealed that Noeline has rhabdomyosarcoma, a soft tissue sarcoma, in her vaginal wall. Simply put, seven-year old Noeline has cancer. To see a video on the Engeye Health Clinic, please visit: http://www.youtube.com/watch?v=lRpcHdwZdkQ

After six rounds of chemotherapy and months of excruciating pain, Noeline’s recent CT scan shows that her tumor has grown in size and is potentially infiltrating her bowels. Noeline is dying. She needs life-saving surgery, though the tumor is much too large to safely remove now. Please help the Engeye team give her the chemotherapy she needs to shrink the tumor down. The cancer can be treated to and give Noeline a second chance at life. The Engeye team needs to raise $3,000 as soon as possible to get Noeline the emergency treatment she needs.

For those who would like to help with this mission, please visit: http://www.engeye.org/support.html and direct the funds to Noeline. Concerned citizens may also send a check to Engeye Inc, 1500 SW 11th Avenue, Suite 2304, Portland, OR 97201. Please mark all donations for Noeline’s Treatment. The Engeye team appreciates any assistance. For more information, please visit: http://www.engeye.org/aboutus/history/84-noeline.html or email info@engeye.org.

About the Engeye Health Clinic
Engeye, a U.S. and Ugandan NGO based in Uganda, was created in 2006 by a dedicated group of medical students to address the disparity in basic health, education and environmental needs of rural Ugandan villagers. Since its inception, the Engeye team has grown to include lawyers, architects, physicians, public health enthusiasts, engineers and more. The Engeye Health Clinic provides care for a region in Uganda that is voiceless, despite its substantial need, and that otherwise would not have access to healthcare. The Engeye Scholars program was born to assist the schools in Ddegeya Village. Education is highly valued in Uganda and many experts believe education is the key to raising poor countries out of poverty. Through scholarships, the children of Ddegeya Village have the opportunity to attend boarding school, which delays child bearing, empowers women and provides newfound hope for a child to fulfill his or her dreams. Dr. Stephanie Van Dyke, Dr. Carlos Elguero, Dr. James Walker, Misty Richards, Stephen Po-Chedley, John Leisure and Keith DesRochers comprise the board of directors for the 501(c) (3) tax deductible, nonprofit organization. For more information, visit: www.engeye.org and www.engeyescholars.org

###

Article source: Read More

Mechdyne to Demonstrate Latest Simulation Technologies at the International Meeting on Simulation in Healthcare 2012

Posted by: Doctor Medical  :  Category: Health

Marshalltown, IA, January 27, 2012 –(PR.com)– Mechdyne Corporation will demonstrate the latest in immersive simulation technologies at this year’s International Meeting on Simulation in Healthcare (IMSH) 2012. The conference will take place January 29 – 31, 2012, at the San Diego Convention Center in San Diego, California.

In partnership with the Uniformed Services University of the Health Services (USUHS) National Capital Area Medical Simulation Center (SimCen), Mechdyne will provide a Wide Area Virtual Environment (WAVElet). Together, Mechdyne and SimCen will integrate virtual reality, live actors, patient simulators and part tasks trainers to create a comprehensive medical team training environment.

Each day of the conference, they will utilize the WAVE, which was designed, engineered and integrated by Mechdyne, to conduct a number of emergency and disaster response scenarios. The simulated medical training demonstrations will take place three times a day at the conference, as part of the Military Medical Simulation and Training Consortium exhibition, in booth #18.

The WAVE that will be utilized at IMSH 2012 was custom designed by Mechdyne and is the second immersive solution the technology company has provided for the National Capital Area Medical Simulation Center at USUHS. Mechdyne designed and integrated USUHS’ first immersive system in 2005. The second generation WAVE utilized at IMSH 2012 is part of a total medical simulation solution Mechdyne will install at SimCen later this year.

IMSH 2012 offers a wide range of educational and networking opportunities for healthcare professionals interested in the field of medical simulation. As part of the international conference, Kurt Hoffmeister, Vice President of Research and Development for Mechdyne, will serve as a panelist for a session entitled “The State of the Art and Challenges in 3D Immersive and Holographic Imaging Technology Applied to Medical Modeling and Simulation.” The focus for Hoffmeister’s presentation will be “3D Immersive Display Challenges for Medical Modeling and Simulation.”

About Mechdyne Corporation
Mechdyne Corporation is one of the world’s largest companies dedicated to consulting and development of turnkey advanced Audio Visual (AV), immersive 3D, networked, and collaborative visualization solutions.

Mechdyne addresses complex projects where in-depth understanding of user requirements leads to the development of products and customized solutions involving elements of display, graphics computing, software, and professional services.

Headquartered in Marshalltown, Iowa, with offices around the world, Mechdyne serves a global customer base. Our customers include: leading government laboratories, Department of Defense (Army, Navy, Air Force), energy companies, universities and research labs, medical, manufacturing, and other users of advanced technology. More information is available at www.mechdyne.com.

###

Article source: Read More

Corrective Exercise Expert Anthony Carey Offers the Latest Information on Health and Healing in Online Interview

Posted by: Doctor Medical  :  Category: Health

Rancho Santa Margarita, CA, January 27, 2012 –(PR.com)– While a regular exercise routine can boost heart health, lung capacity and life span, exercise can also lead to injuries and imbalances. In that case, it’s important to understand the best options when it comes to therapeutic exercises, corrective exercises and post-rehab exercises, all discussed in detail by corrective exercise expert Anthony Carey on John Spencer Ellis’ recent video blog.

The video blog breaks down complex science into easy-to-understand concepts and terminology for personal trainers, coaches, fitness pros and athletes looking for more information on corrective exercise. In particular, Carey explains that:

Therapeutic exercises are based on physical therapy and are part of a treatment protocol, an exercise program structured around the rehabilitation of a particular injury.

Corrective exercises focus on identifying incorrect patterns of movement, identifying what muscles are weak or strong, lengthened or shortened, and what can be done to correct imbalances in the body.

Post-rehab exercises are exercises that can be therapeutic in nature, but chiefly focus on long-term treatment for a client’s holistic health. Post-rehab exercises can be step one and lead into corrective exercises.

“Regardless of what you do to get fit, it’s important to understand how you can improve the quality of your movement, so you can avoid compounding existing problems and get the most of your ongoing workouts,” said Ellis, founder of John Spencer Ellis Enterprises, a fitness and personal development solutions company. “Whether you have an injury or are a personal trainer working with clients with injuries, understanding corrective exercises can make a big difference in your long-term health and productivity.”

The online interview also discusses misconceptions and misinformation about this aspect of the fitness industry as well as different definitions of functional and sports-specific exercises. In addition, it addresses the importance of understanding these exercises, as well as more passive healing modalities, for fitness professionals, whether they are looking to heal from an injury, improve performance or train for an event.

About John Spencer Ellis Enterprises
John Spencer Ellis Enterprises is a solutions provider for fitness and coaching professionals around the world, providing education, turn-key business programs, coaching and resources for new and advanced fitness and coaching professionals. For more information about John Spencer Ellis Enterprises or the Anthony Carey video blog interview on corrective exercises, please visit http://johnspencerellis.com/anthony-carey-interview-with-john-spencer-ellis-therapeutic-exercises-vs-corrective-exercises-vs-post-rehab-exercises/

###

Article source: Read More

Allscripts Adds M*Modal’s Speech Understanding™ to EHR Platforms and Mobility Solutions

Posted by: Doctor Medical  :  Category: Health News

FRANKLIN, Tenn.–(BUSINESS WIRE)–MModal Inc.(NASDAQ/GS: MODL), a leading provider of clinical narrative
capture services, Speech Understanding™ technology and clinical
documentation workflow, today announced that it has entered into a
strategic reseller and development relationship with Allscripts (NASDAQ:
MDRX) for its speech and language understanding technology, which will
be available in key solutions for Allscripts clients across all
ambulatory and acute-care platforms. The relationship will provide
capabilities to create content-rich, voice-driven narrative patient
documentation within Allscripts electronic health record (EHR) systems.

“We are firmly committed to open software that delivers intuitive user
experience and captures complete, accurate, and high-quality patient
information”

M*Modal’s technology, based on its Speech Understanding™ and Natural
Language Understanding (NLU) platform, will empower Allscripts
market-leading EHRs, providing Allscripts clients with innovative new
technology focused on making electronic health records easier to learn
and use. The integration supports Allscripts commitment to offer
flexible note-creation options.

In addition, Allscripts is incorporating the M*Modal technology into its
mobility offerings including its Sunrise Mobile™ MD II product for
on-the-go speech understanding capability. Using Sunrise Mobile for the
iPad®, physicians can view complete patient context, use real-time
speech to create immediate and detailed progress reports and other
clinical notes, and have this documentation available to drive actions
in the Allscripts Sunrise Clinical Manager™ system.

“We are firmly committed to open software that delivers intuitive user
experience and captures complete, accurate, and high-quality patient
information,” said Glen Tullman, Chief Executive Officer of Allscripts.
“M*Modal’s technology optimizes the physician’s ability to generate a
detailed story very efficiently in our Enterprise EHR platform from
either the workstation or a mobile device.”

M*Modal’s technology takes advantage of its cloud-based enterprise
documentation platform to enable healthcare providers to speech-enable
existing health information systems including EHRs, radiology
information systems (RIS) and picture archiving and communication
systems (PACS). Providers can use their voice, in addition to keyboard
and mouse, to seamlessly interact with their desktop clinical
applications, including the dictation of medical narrative and voice
navigation within 3rd-party applications. Using this
solution, providers can improve documentation efficiency and avoid
difficulties associated with template-based point-and-click systems,
augmenting discretely captured data with a narrative of the patient’s
story. This ultimately improves the quality of clinical documentation.

“Allscripts is a leader in EHR technology and a demonstrated innovator
in the healthcare industry,” said Vern Davenport, Chairman and CEO of
M*Modal. “We are pleased to collaborate with Allscripts to bring its
large enterprise physician user-base our innovative technology to
generate meaningful, actionable clinical content in ways that respect
how they want to document patient encounters. With more than 165,000
physicians using M*Modal technology and services, we are poised to
provide even greater value to ambulatory providers and, ultimately,
patients.”

About Allscripts

Allscripts (NASDAQ: MDRX)
delivers the insights that healthcare providers require to generate
world-class outcomes. The company’s Electronic Health Record, practice
management and other clinical, revenue cycle, connectivity and
information solutions create a Connected Community of Health™
for physicians, hospitals and post-acute organizations. To learn more
about Allscripts, please visit www.allscripts.com,
Twitter,
Facebook
and YouTube.

About M*Modal

M*Modal (NASDAQ/GS: MODL)is a leading provider of clinical narrative
capture services, Speech Understanding™ technology and clinical
documentation workflow. M*Modal’s enterprise solutions – including
mobile voice capture devices, speech recognition, Natural Language
Understanding, Web-based workflow platforms and global network of
medical editors – help healthcare facilities facilitate adoption of
electronic health records (EHR), transition to ICD-10, improve patient
care, increase physician satisfaction and lower operational costs. For
more information, please visit www.mmodal.com,
Twitter, Facebook and YouTube.

Forward-Looking Statements

Information provided and statements contained in this press release
that are not purely historical, such as statements regarding our
expectations regarding our future business plans are forward-looking
statements within the meaning of Section 27A of the Securities Act of
1933, Section 21E of the Securities Exchange Act of 1934 and the Private
Securities Litigation Reform Act of 1995. Such forward-looking
statements only speak as of the date of this press release and the
Company assumes no obligation to update the information included in this
press release. Statements made in this press release that are
forward-looking in nature may involve risks and uncertainties.
Accordingly, readers are cautioned that any such forward-looking
statements are not guarantees of future performance and are subject to
certain risks, uncertainties and assumptions that are difficult to
predict, including, without limitation, specific factors discussed
herein and in other releases and public filings made by the Company
(including filings by the Company with the Securities and Exchange
Commission). Although the Company believes that the expectations
reflected in such forward-looking statements are reasonable as of the
date made, expectations may prove to have been materially different from
the results expressed or implied by such forward-looking statements.
Unless otherwise required by law, the Company also disclaims any
obligation to update its view of any such risks or uncertainties or to
announce publicly the result of any revisions to the forward-looking
statements made in this press release.

Article source: Read More

P&G Announces Second Quarter Results; Delivers 4% Organic Sales Growth, Core EPS of $1.10

Posted by: Doctor Medical  :  Category: Health News

CINCINNATI–(BUSINESS WIRE)–The Procter Gamble Company (NYSE:PG) delivered four percent sales
growth to $22.1 billion for the October – December quarter. Growth was
driven by higher volume and pricing actions, partially offset by
geographic and product mix. The Company continued to deliver broad-based
organic sales growth, with all six business segments up versus the prior
year. Diluted net earnings per share were $0.57 per share, reflecting
non-core charges of $0.53 per share. The non-core items included a $0.50
per share non-cash impairment charge associated with the Appliances and
Salon Professional businesses. Core net earnings per share were $1.10,
toward the high end of the Company’s expectations for the quarter.

“We continue to make progress against our key business priorities in a
difficult macroeconomic environment”

“We continue to make progress against our key business priorities in a
difficult macroeconomic environment,” said Chairman of the Board,
President and Chief Executive Officer Bob McDonald. “We delivered solid
top-line growth and continued to accelerate productivity improvements to
drive down costs. With the easing of commodity cost comparisons over the
next two quarters, continued solid top-line growth and cost savings
progress, we expect operating profit growth to accelerate in the second
half of the fiscal year.”

Executive Summary

  • Net sales and organic sales increased four percent for the quarter.
  • Organic sales growth was broad-based, with all six business segments
    growing for the second consecutive quarter.
  • Core net earnings per share decreased three percent to $1.10. The
    benefits from solid sales growth and cost savings were more than
    offset by higher commodity costs.
  • Diluted net earnings per share were $0.57 per share, down 49 percent
    primarily due to non-core charges of $0.53 per share. The non-core
    charges included a one-time $0.50 per share non-cash impairment charge
    associated with the Appliances and Salon Professional businesses.
  • Operating cash flow was $3.3 billion for the quarter.

October – December Quarter Discussion

Net sales increased four percent to $22.1 billion in the October –
December quarter. Organic sales also grew four percent. Volume increased
one percent behind overall market growth, initiatives and continued
market expansions. Volume grew at high single-digit rates in developing
regions. This growth was partially offset by a mid-single-digit decrease
in developed regions. Broad-based price increases across all segments
and geographies, designed to recover higher commodity costs and
devaluing developing market currencies, increased net sales by four
percent. Geographic and product mix reduced net sales by one percent.

Diluted net earnings per share were $0.57, a decrease of 49 percent
primarily due to non-core charges of $0.53 per share which include a
$0.50 per share non-cash impairment charge. Gross margin contracted 210
basis points due mainly to higher commodity costs, partially offset by
pricing and manufacturing cost savings. Selling, general and
administrative expenses (SGA) as a percentage of net sales improved 150
basis points behind net sales leverage, a reduction in overhead spending
and lower charges for non-core items. Including the impact of non-core
items, operating margin declined 760 basis points.

Excluding the non-core items, core net earnings per share were $1.10,
and core operating margin declined 160 basis points.

Operating cash flow was $3.3 billion for the quarter and free cash flow
was $2.4 billion. The Company repurchased $0.5 billion of shares during
the quarter and returned $1.5 billion of cash to shareholders as
dividends.

Goodwill and Intangibles Impairment

During the quarter, the Company took a non-cash charge of $1.5 billion
after tax, or $0.50 per share, to adjust the carrying values of goodwill
in the Appliances and Salon Professional businesses, and trade name
intangible assets in the Salon Professional business. The impairments
were primarily driven by the prolonged deterioration of the
macroeconomic environment, the more discretionary nature of the
products, and increasing levels of competitive activity. Together, these
factors have led to a reduction in expected market size and growth rates
for both businesses. This is particularly the case in the Western Europe
market, where roughly 50 percent of PG’s Appliances and Salon
Professional sales are generated. As a result of these factors, the
Company recently has reduced the sales, earnings and cash flow forecasts
for these businesses.

Business Segment Discussion

  • Beauty net sales increased one percent to $5.4 billion on unit volume
    growth of one percent. Organic sales grew two percent on two percent
    organic volume growth. Price increases added three percent to net
    sales growth. Mix reduced net sales by four percent due to
    disproportionate growth in developing regions, which have lower than
    segment average selling prices, and a decrease in the premium-priced
    product categories. Favorable foreign exchange increased net sales by
    one percent. Volume grew high single digits in developing markets and
    decreased mid-single digits in developed regions. Volume in Hair Care
    increased mid-single digits behind high-single-digit growth in
    developing regions due to product innovation activity and distribution
    expansions in Asia, while developed regions decreased mid-single
    digits. Volume in Skin Care, Personal Care and Cosmetics decreased low
    single digits due to the Zest and Infasil divestitures, Olay share
    loss in developed markets and the volume impact of price increases due
    to consumer value differences relative to competitive products in
    North America. Volume in Salon Professional declined high single
    digits due to market contraction in Europe, distribution share losses
    and non-strategic brand discontinuations. Volume in Prestige Products
    decreased low single digits driven by minor brand divestitures and a
    strong initiative base in the prior year, offset by current year
    market growth and initiatives for SK-II. Net earnings declined eight
    percent to $802 million as higher commodity costs more than offset the
    impact of sales growth.
  • Grooming net sales increased one percent to $2.2 billion. Unit volume
    increased one percent. Organic sales were up two percent. Price
    increases added two percent to net sales growth, while unfavorable
    product mix decreased net sales by two percent mainly due to a
    reduction in premium appliances, which have higher than segment
    average selling prices. Volume grew high single digits in developing
    regions and decreased mid-single digits in developed regions. Shave
    Care volume grew low single digits due to high single-digit growth in
    developing regions behind product and commercial innovation, Fusion
    ProGlide geographic expansion and market growth, partially offset by a
    mid-single-digit decrease in developed regions due to market
    contraction and competitive activity. Volume in Appliances decreased
    double digits primarily due to a decrease in Western Europe as markets
    contracted and competitive activity increased. Net earnings increased
    two percent to $517 million, largely consistent with net sales growth.
    The decline in gross margin due to unfavorable geographic and product
    mix was offset by lower SGA.
  • Health Care net sales and organic sales increased one percent to $3.2
    billion on unit volume that was in line with the prior year period.
    Pricing increased net sales by three percent. Unfavorable product and
    geographic mix reduced net sales by two percent. Volume increased low
    single digits in developing regions and decreased low single digits in
    developed regions. Oral Care volume decreased low single digits due to
    a strong initiative base period in North America and current
    competitive activity. Volume in Feminine Care grew low single digits
    driven by mid-single digit growth in developing markets due to a new
    distributor start-up in CEEMEA and market growth and product
    innovation in India, partially offset by a mid-single digit decrease
    in developed regions due to competitive activity, primarily in North
    America. Personal Health Care volume increased mid-single digits
    primarily due to the addition of the Teva partnership, with organic
    volume increasing low single digits behind market growth and Vicks
    product innovation, partially offset by lower shipments of Prilosec
    OTC in North America. Net earnings increased one percent to $537
    million, consistent with sales growth, as reduced gross margins were
    offset by lower SGA as a percentage of net sales.
  • Snacks and Pet Care net sales and organic sales increased three
    percent to $824 million on a two percent increase in unit volume.
    Pricing increased net sales by three percent. Mix reduced net sales by
    two percent due to unfavorable product and geographic mix. Snacks
    volume increased mid-single digits mainly due to increased
    distribution and market growth in developing regions. Pet Care volume
    decreased low single digits due to customer inventory adjustments and
    market contraction. Net earnings decreased nine percent to $61 million
    as operating margin contraction and a higher effective tax rate more
    than offset net sales growth. Operating margin decreased primarily due
    to a decline in gross margin, partially offset by a decrease in
    overhead spending as a percentage of net sales. Gross margin decreased
    behind an increase in commodities, partially offset by price increases
    and manufacturing cost savings.
  • Fabric Care and Home Care net sales and organic sales increased five
    percent to $6.6 billion behind six points of increased pricing. Mix
    reduced net sales by one percent due to unfavorable product and
    geographic mix. Unit volume was in line with the prior year period.
    Volume increased high single digits in developing regions, offset by a
    low single digit decrease in developed regions. Fabric Care volume was
    in line with the prior year as a mid-single digit increase in
    developing regions, driven by new innovation and market growth, was
    offset by a mid-single digit decrease in developed regions due to
    competitive activity and the impact of price increases taken in the
    previous quarters. Home Care volume increased low single digits driven
    by initiative activity and distribution expansion in developing
    regions. Batteries volume decreased low single digits due to market
    contraction and distribution losses in developed markets, partially
    offset by market growth and distribution expansion in developing
    regions. Net earnings declined five percent to $717 million as sales
    growth was more than offset by operating margin contraction. Operating
    margin declined primarily due to lower gross margin, as higher
    commodity costs were only partially offset by price increases and
    manufacturing cost savings.
  • Baby Care and Family Care net sales and organic sales increased six
    percent to $4.2 billion driven by six points of increased pricing.
    Unit volume was in line with the prior year period. Volume in
    developing regions increased double digits, while volume in developed
    regions decreased mid-single digits. Volume in Baby Care increased
    mid-single digits behind market size growth, innovation across the
    portfolio, and distribution expansion in developing regions, partially
    offset by market contraction in developed regions. Volume in Family
    Care decreased mid-single digits primarily due to consumer value
    differences relative to competitive products in North America. Net
    earnings increased three percent to $516 million as sales growth was
    partially offset by lower operating margin. Operating margin
    contracted mainly due to a lower gross margin, driven by higher
    commodity costs, partially offset by price increases and manufacturing
    cost savings.

Fiscal Year 2012 Guidance

Net sales are expected to increase three to four percent in fiscal 2012.
Organic sales are expected to increase four to five percent. Foreign
exchange is expected to reduce net sales by one percent for the year.
Pricing is expected to add four percent to sales while unfavorable
product and geographic mix is expected to reduce sales by one to two
percent. Diluted net earnings per share is expected to be in the range
of $3.85 to $4.08 and Core EPS in the range of $4.00 to $4.10, up one to
four percent versus a base period Core EPS of $3.95. The Company’s prior
guidance range for Core EPS was $4.15 to $4.33. The change in the Core
EPS range is primarily due to foreign exchange, which has negatively
impacted earnings per share by $0.15 to $0.18 since the estimates
established at the beginning of the fiscal year.

January – March 2012 Quarter Guidance

For the January – March quarter, net sales growth is estimated to be in
line with year ago to up two percent. Organic sales are expected to grow
three to five percent, with continued benefit from pricing. Foreign
exchange is expected to reduce net sales by three percent. Diluted net
earnings per share are expected to be in the range of $0.81 to $0.87,
with Core EPS in the range of $0.91 to $0.97, down five percent to up
one percent versus a base period Core EPS of $0.96. Third quarter net
earnings will continue to be negatively affected by higher commodity
costs versus prior year levels. In addition, the Company noted that it
expects the effective tax rate will be significantly higher than in the
comparison period, which will reduce Core EPS growth by approximately
seven percent.

Fiscal Year 2012 Second Half Perspective

PG provided additional perspective on the improved results expected in
the second half of the fiscal year. The Company said it expects net
sales growth to be in-line with year ago to up two percent. Organic
sales growth in the range of four percent to five percent driven
primarily by continued strong growth in developing markets. Foreign
exchange is expected to reduce net sales by three to four percent.

The Company added that it expects sequential improvement in core
operating profit in the third and fourth quarters as the benefits from
pricing increase and commodity cost comparisons continue to ease. PG
said it expects double-digit growth in core operating profit for the
second-half of the fiscal year.

Core earnings per share growth rates will be driven by the strong
operating profit growth, but will be partially offset by a significant
increase in the effective tax rate. The Company’s new guidance
translates to four percent to nine percent core EPS growth in the second
half of the fiscal year, which includes an approximate six percentage
point negative impact on core EPS growth from the higher tax rate.

Forward-Looking Statements

All statements, other than statements of historical fact included in
this release or presentation, are forward-looking statements, as that
term is defined in the Private Securities Litigation Reform Act of 1995.
Such statements are based on financial data, market assumptions and
business plans available only as of the time the statements are made,
which may become out of date or incomplete. We assume no obligation to
update any forward-looking statement as a result of new information,
future events or other factors. Forward-looking statements are
inherently uncertain, and investors must recognize that events could
differ significantly from our expectations. In addition to the risks and
uncertainties noted in this release or presentation, there are certain
factors that could cause actual results for any quarter or annual period
to differ materially from those anticipated by some of the statements
made. These include: (1) the ability to achieve business plans,
including growing existing sales and volume profitably despite high
levels of competitive activity and an increasingly volatile economic
environment, especially with respect to the product categories and
geographical markets (including developing markets) in which the Company
has chosen to focus; (2) the ability to successfully manage ongoing
acquisition, divestiture and joint venture activities to achieve the
cost and growth synergies in accordance with the stated goals of these
transactions without impacting the delivery of base business objectives;
(3) the ability to successfully manage ongoing organizational changes
designed to support our growth strategies, while successfully
identifying, developing and retaining key employees, especially in key
growth markets where the availability of skilled employees is limited;
(4) the ability to manage and maintain key customer relationships; (5)
the ability to maintain key manufacturing and supply sources (including
sole supplier and plant manufacturing sources); (6) the ability to
successfully manage regulatory, tax and legal requirements and matters
(including product liability, patent, intellectual property, and tax
policy), and to resolve pending matters within current estimates; (7)
the ability to resolve the pending competition law inquiries in Europe
within current estimates; (8) the ability to successfully implement,
achieve and sustain cost improvement plans in manufacturing and overhead
areas, including the Company’s outsourcing projects; (9) the ability to
successfully manage currency (including currency issues in certain
countries, such as Venezuela, China and India), debt, interest rate and
commodity cost exposures and significant credit or liquidity issues;
(10) the ability to manage continued global political and/or economic
uncertainty and disruptions, especially in the Company’s significant
geographical markets, due to terrorist and other hostile activities or
natural disasters (including the civil unrest in the Middle East and the
Japan earthquake and tsunami) and/or disruptions to credit markets
resulting from a global, regional or national credit crisis; (11) the
ability to successfully manage competitive factors, including prices,
promotional incentives and trade terms for products; (12) the ability to
obtain patents and respond to technological advances attained by
competitors and patents granted to competitors; (13) the ability to
successfully manage increases in the prices of raw materials used to
make the Company’s products; (14) the ability to develop effective
sales, advertising and marketing programs; (15) the ability to stay on
the leading edge of innovation, maintain a positive reputation on our
brands and ensure trademark protection; and (16) the ability to rely on
and maintain key information technology systems (including Company and
third-party systems) and the security over such systems and the data
contained therein. For additional information concerning factors that
could cause actual results to materially differ from those projected
herein, please refer to our most recent 10-K, 10-Q and 8-K reports.

About Procter Gamble

PG serves approximately 4.4 billion people around the world with its
brands. The Company has one of the strongest portfolios of trusted,
quality, leadership brands, including Pampers®, Tide®, Ariel®, Always®,
Whisper®, Pantene®, Mach3®, Bounty®, Dawn®, Fairy®, Gain®, Pringles®,
Charmin®, Downy®, Lenor®, Iams®, Crest®, Oral-B®, Duracell®, Olay®, Head
Shoulders®, Wella®, Gillette®, Braun®, Fusion®, Ace®, Febreze®, and
Ambi Pur®. The PG community includes operations in about 80 countries
worldwide. Please visit http://www.pg.com
for the latest news and in-depth information about PG and its brands.

# # #

The Procter Gamble Company

Exhibit 1: Non-GAAP Measures

In accordance with the SEC’s Regulation G, the following provides
definitions of the non-GAAP measures used in the earnings release and
the reconciliation to the most closely related GAAP measure.

Organic Sales Growth: Organic sales growth
is a non-GAAP measure of sales growth excluding the impacts of
acquisitions, divestitures and foreign exchange from year-over-year
comparisons. We believe this provides investors with a more complete
understanding of underlying sales trends by providing sales growth on a
consistent basis. Organic sales is also one of the measures used to
evaluate senior management and is a factor in determining their at-risk
compensation.

The reconciliation of reported sales growth to organic sales is as
follows:

 

 

 

 

OND 2011

Net
Sales
Growth

Foreign
Exchange
Impact

Acquisition/
Divestiture
Impact*

Organic
Sales
Growth

Beauty

1%

-1%

2%

2%

Grooming

1%

0%

1%

2%

Health Care

1%

0%

0%

1%

Snacks and Pet Care

3%

0%

0%

3%

Fabric Care and Home Care

5%

0%

0%

5%

Baby Care and Family Care

 

6%

 

0%

 

0%

 

6%

Total PG

 

4%

 

0%

 

0%

 

4%

 

Total PG

Net Sales
Growth

Foreign
Exchange
Impact

Acquisition/
Divestiture
Impact*

Organic
Sales
Growth

JFM 12 (estimate)

0% to 2%

3%

0%

3% to 5%

2H FY 2012 (estimate)

0% to 2%

4% to 3%

0%

4% to 5%

FY 2012 (estimate)

 

3% to 4%

 

1%

 

0%

 

4% to 5%

*Acquisition/Divestiture Impact includes rounding impacts necessary to
reconcile net sales to organic sales.

Core EPS: This is a measure of the
Company’s diluted net earnings per share from continuing operations
excluding current year impairment charges for goodwill and indefinite
lived intangible assets, current year charges related to incremental
restructuring charges due to increased focus on productivity and cost
savings, charges in both years related to the European legal matters and
a significant prior year settlement from U.S. tax litigation related to
the valuation of technology donations. We do not view these items to be
part of our sustainable results. We believe the Core EPS measure
provides an important perspective of underlying business trends and
results and provides a more comparable measure of year-on-year earnings
per share growth. Core EPS is also one of the measures used to evaluate
senior management and is a factor in determining their at-risk
compensation. The table below provides a reconciliation of diluted net
earnings per share to Core EPS:

 

 

 

 

 

OND 11

OND 10

Diluted Net Earnings Per Share

$0.57

 

$1.11

Impairment charges

$0.50

-

Charges for European legal matters

$0.02

$0.10

Settlement from U.S. tax litigation

-

($0.08)

Incremental restructuring

$0.01

-

Core EPS

$1.10

 

$1.13

Core EPS Growth

-3%

 

 

JFM 12 (Est.)

JFM 11

Diluted Net Earnings Per Share

$0.81 to $0.87

 

$0.96

Incremental Restructuring

$0.10

-

Core EPS

$0.91 to $0.97

 

$0.96

Core EPS Growth

-5% to 1%

 

 

Jan-Jun 2012 (Est.)

Jan-Jun 2011

Diluted Net Earnings Per Share

$2.25 to $2.48

$1.80

One-time gain from snacks divestiture

($0.55) to ($0.65)

-

Incremental restructuring

$0.17 to $0.14

-

Core EPS

$1.87 to $1.97

$1.80

Core EPS Growth

4% to 9%

 

 

 

FY 2012 (Est.)

FY 2011

Diluted Net Earnings Per Share

$3.85 to $4.08

$3.93

One-time gain from snacks divestiture

($0.55) to ($0.65)

-

Impairment charges

$0.50

-

Charges for European legal matters

$0.02

$0.10

Settlement from U.S. tax litigation

-

($0.08)

Incremental restructuring

$0.18 to $0.15

-

Core EPS

$4.00 to $4.10

$3.95

Core EPS Growth

1% to 4%

 

Note – All reconciling items are presented net of tax. Tax effects are
calculated consistent with the nature of the underlying transaction. The
charge for the significant settlement from U.S. tax litigation is tax
expense.

Core Operating Margin: This is a measure of
the Company’s operating margin adjusted for the current year impairment
charges for goodwill and indefinite lived intangible assets, current
year charges related to incremental restructuring charges due to
increased focus on productivity and cost savings, and charges in current
and prior year related to the European legal matters:

 

 

 

 

 

 

 

 

 

OND 11

OND 10

Operating Margin

12.4%

 

20.0%

Impairment charges

7.0%

-

Charges for European legal matters

0.3%

1.4%

Incremental restructuring

0.1%

-

Core Operating Margin

19.8%

 

21.4%

Basis point change

-160 bps

 

Core Operating Profit Growth: This is a
measure of the Company’s operating profit growth adjusted for the
current year impairment charges for current year charges related to
incremental restructuring charges due to increased focus on productivity
and cost savings:

 

 

 

 

 

 

 

Jan-Jun 2012
(Est.)

Operating Profit Growth

0% to 7%

Impairment charges

-

Charges for European legal matters

-

Incremental restructuring

10% to 8%

Rounding

-

Core Operating Profit Growth

10% to 15%

 

Free Cash Flow: Free cash flow is defined
as operating cash flow less capital spending. We view free cash flow as
an important measure because it is one factor in determining the amount
of cash available for dividends and discretionary investment. Free cash
flow is also one of the measures used to evaluate senior management and
is a factor in determining their at-risk compensation. The
reconciliation of free cash flow is provided below (amounts in millions):

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating
Cash Flow

 

 

 

Capital
Spending

 

 

 

Free Cash Flow

Oct-Dec ‘11

 

 

 

$3,328

 

 

 

($947)

 

 

 

$2,381

 

 

 

 

 

 

 

THE PROCTER GAMBLE COMPANY AND SUBSIDIARIES

(Amounts in Millions Except Per Share Amounts)

Consolidated Earnings Information

 

 

 

 

 

 

 

 

 

 

Three Months Ended December 31

Six Months Ended December 31

2011

2010

% CHG

2011

2010

% CHG

NET SALES

$

22,135

$

21,347

4

%

$

44,052

$

41,469

6

%

COST OF PRODUCTS SOLD

 

11,125

 

 

10,287

 

8

%

 

22,186

 

 

19,976

 

11

%

GROSS PROFIT

11,010

11,060

(0

)%

21,866

21,493

2

%

SELLING, GENERAL ADMINISTRATIVE EXPENSE

6,717

6,800

(1

)%

13,239

12,732

4

%

GOODWILL INDEFINITE LIVED INTANGIBLE IMPAIRMENT CHARGES

 

1,554

 

 

0

 

-

 

1,554

 

 

0

 

-

OPERATING INCOME

2,739

4,260

(36

)%

7,073

8,761

(19

)%

TOTAL INTEREST EXPENSE

201

209

(4

)%

408

417

(2

)%

OTHER NON-OPERATING INCOME/(EXPENSE), NET

 

170

 

 

39

 

336

%

 

171

 

 

67

 

155

%

EARNINGS BEFORE INCOME TAXES

2,708

4,090

(34

)%

6,836

8,411

(19

)%

INCOME TAXES

995

728

37

%

2,066

1,929

7

%

 

NET EARNINGS

1,713

3,362

(49

)%

4,770

6,482

(26

)%

LESS: NET EARNINGS ATTRIBUTABLE TO NONCONTROLLING INTERESTS

 

23

 

 

29

 

(21

)%

 

56

 

 

68

 

(18

)%

NET EARNINGS ATTRIBUTABLE TO PROCTER GAMBLE

 

1,690

 

 

3,333

 

(49

)%

 

4,714

 

 

6,414

 

(27

)%

 

EFFECTIVE TAX RATE

36.7

%

17.8

%

30.2

%

22.9

%

 

 

PER COMMON SHARE:

BASIC NET EARNINGS

$

0.59

$

1.17

(50

)%

$

1.67

$

2.24

(25

)%

 

DILUTED NET EARNINGS

$

0.57

$

1.11

(49

)%

$

1.60

$

2.13

(25

)%

 

DIVIDENDS

$

0.5250

$

0.4818

9

%

$

1.0500

$

0.9636

9

%

AVERAGE DILUTED SHARES OUTSTANDING

2,949.7

3,000.2

2,946.5

3,013.0

 

 

 

COMPARISONS AS A % OF NET SALES

Basis Pt
Chg

Basis Pt
Chg

GROSS MARGIN

49.7

%

51.8

%

(210

)

49.6

%

51.8

%

(220

)

SELLING, GENERAL ADMINISTRATIVE EXPENSE

30.3

%

31.8

%

(150

)

30.0

%

30.7

%

(70

)

GOODWILL INDEFINITE LIVED INTANGIBLE IMPAIRMENT CHARGES

7.0

%

0.0

%

700

3.5

%

0.0

%

350

OPERATING MARGIN

12.4

%

20.0

%

(760

)

16.1

%

21.1

%

(500

)

EARNINGS BEFORE INCOME TAXES

12.2

%

19.2

%

(700

)

15.5

%

20.3

%

(480

)

NET EARNINGS ATTRIBUTABLE TO PROCTER GAMBLE

7.6

%

15.6

%

(800

)

10.7

%

15.5

%

(480

)

 

 

 

 

 

 

 

THE PROCTER GAMBLE COMPANY AND SUBSIDIARIES

(Amounts in Millions)

Consolidated Cash Flows Information

 

 

 

 

 

Six Months Ended December 31

2011

2010

 

CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD

$

2,768

$

2,879

 

OPERATING ACTIVITIES

NET EARNINGS

4,770

6,482

DEPRECIATION AND AMORTIZATION

1,456

1,400

SHARE-BASED COMPENSATION EXPENSE

168

180

DEFERRED INCOME TAXES

32

142

GAIN ON SALE OF BUSINESSES

(187

)

(3

)

GOODWILL AND INDEFINITE LIVED INTANGIBLES IMPAIRMENT CHARGES

1,554

0

CHANGES IN:

ACCOUNTS RECEIVABLE

(1,079

)

(931

)

INVENTORIES

(497

)

(779

)

ACCOUNTS PAYABLE, ACCRUED AND OTHER LIABILITIES

(1,009

)

(377

)

OTHER OPERATING ASSETS LIABILITIES

230

(671

)

OTHER

 

57

 

 

(67

)

 

TOTAL OPERATING ACTIVITIES

 

5,495

 

 

5,376

 

 

INVESTING ACTIVITIES

CAPITAL EXPENDITURES

(1,780

)

(1,256

)

PROCEEDS FROM ASSET SALES

238

22

ACQUISITIONS, NET OF CASH ACQUIRED

2

(435

)

CHANGE IN INVESTMENTS

 

71

 

 

128

 

 

TOTAL INVESTING ACTIVITIES

 

(1,469

)

 

(1,541

)

 

FINANCING ACTIVITIES

DIVIDENDS TO SHAREHOLDERS

(3,013

)

(2,834

)

CHANGE IN SHORT-TERM DEBT

2,416

948

ADDITIONS TO LONG-TERM DEBT

1,990

1,536

REDUCTIONS OF LONG-TERM DEBT

(2,514

)

(160

)

TREASURY STOCK PURCHASES

(1,764

)

(3,528

)

IMPACT OF STOCK OPTIONS AND OTHER

 

589

 

 

463

 

 

TOTAL FINANCING ACTIVITIES

 

(2,296

)

 

(3,575

)

 

EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS

 

(84

)

 

110

 

 

CHANGE IN CASH AND CASH EQUIVALENTS

 

1,646

 

 

370

 

 

CASH AND CASH EQUIVALENTS, END OF PERIOD

$

4,414

 

$

3,249

 

 

 

 

 

 

THE PROCTER GAMBLE COMPANY AND SUBSIDIARIES

(Amounts in Millions)

Consolidated Balance Sheet Information

 

 

 

December 31, 2011

June 30, 2011

 

CASH AND CASH EQUIVALENTS

$

4,414

$

2,768

ACCOUNTS RECEIVABLE

6,905

6,275

TOTAL INVENTORIES

7,444

7,379

OTHER

 

4,888

 

5,548

TOTAL CURRENT ASSETS

23,651

 

 

 

 

21,970

 

NET PROPERTY, PLANT AND EQUIPMENT

20,372

21,293

NET GOODWILL AND OTHER INTANGIBLE ASSETS

85,632

90,182

OTHER NON-CURRENT ASSETS

 

4,656

 

4,909

 

TOTAL ASSETS

$

134,311

$

138,354

 

 

ACCOUNTS PAYABLE

$

6,735

$

8,022

ACCRUED AND OTHER LIABILITIES

8,939

9,290

DEBT DUE WITHIN ONE YEAR

 

14,118

 

9,981

TOTAL CURRENT LIABILITIES

29,792

27,293

 

LONG-TERM DEBT

19,270

22,033

OTHER

 

20,349

 

21,027

TOTAL LIABILITIES

 

69,411

 

70,353

 

 

TOTAL SHAREHOLDERS’ EQUITY

 

64,900

 

68,001

 

 

TOTAL LIABILITIES SHAREHOLDERS’ EQUITY

$

134,311

$

138,354

 

 

THE PROCTER GAMBLE COMPANY AND SUBSIDIARIES

(Amounts in Millions)

Consolidated Earnings Information

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended December 31, 2011

Net Sales

 

% Change
Versus
Year Ago

 

Earnings Before
Income Taxes

 

% Change
Versus
Year Ago

 

Net Earnings
Attributable to
Procter Gamble

 

% Change
Versus
Year Ago

Beauty

$

5,353

 

1

%

 

$

1,014

 

-9

%

 

$

802

 

-8

%

Grooming

2,202

1

%

692

4

%

517

2

%

Health Care

3,183

1

%

784

1

%

537

1

%

Snacks and Pet Care

824

3

%

95

2

%

61

-9

%

Fabric Care and Home Care

6,605

5

%

1,151

-1

%

717

-5

%

Baby Care and Family Care

4,162

6

%

816

2

%

516

3

%

Corporate

 

(194

)

 

N/A

 

 

 

(1,844

)

 

N/A

 

 

 

(1,460

)

 

N/A

 

Total Company

22,135

4

%

2,708

-34

%

1,690

-49

%

 

 

 

 

 

 

 

 

 

 

 

 

Six Months Ended December 31, 2011

Net Sales

 

% Change
Versus
Year Ago

 

Earnings Before
Income Taxes

 

% Change
Versus
Year Ago

 

Net Earnings
Attributable to
Procter Gamble

 

% Change
Versus
Year Ago

Beauty

$

10,668

5

%

$

1,942

-9

%

$

1,485

-10

%

Grooming

4,370

6

%

1,331

6

%

1,003

5

%

Health Care

6,474

6

%

1,584

4

%

1,079

5

%

Snacks and Pet Care

1,600

6

%

185

9

%

123

2

%

Fabric Care and Home Care

13,286

5

%

2,414

-7

%

1,522

-10

%

Baby Care and Family Care

8,241

9

%

1,608

4

%

1,010

4

%

Corporate

 

(587

)

 

N/A

 

 

 

(2,228

)

 

N/A

 

 

 

(1,508

)

 

N/A

 

Total Company

44,052

6

%

6,836

-19

%

4,714

-27

%

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended December 31, 2011

(Percent Change vs. Year Ago) *

Volume
With
Acquisitions/
Divestitures

 

Volume
Without
Acquisitions/
Divestitures

 

Foreign Exchange

 

Price

 

Mix/Other

 

Net Sales
Growth

Beauty

1

%

2

%

1

%

3

%

-4

%

1

%

Grooming

1

%

1

%

0

%

2

%

-2

%

1

%

Health Care

0

%

0

%

0

%

3

%

-2

%

1

%

Snacks and Pet Care

2

%

2

%

0

%

3

%

-2

%

3

%

Fabric Care and Home Care

0

%

0

%

0

%

6

%

-1

%

5

%

Baby Care and Family Care

 

0

%

 

0

%

 

 

0

%

 

6

%

 

 

0

%

 

6

%

Total Company

1

%

1

%

0

%

4

%

-1

%

4

%

 

 

 

 

 

 

 

 

 

 

 

 

Six Months Ended December 31, 2011

(Percent Change vs. Year Ago) *

Volume
With
Acquisitions/
Divestitures

 

Volume
Without
Acquisitions/
Divestitures

 

Foreign Exchange

 

Price

 

Mix/Other

 

Net Sales
Growth

Beauty

3

%

4

%

3

%

2

%

-3

%

5

%

Grooming

1

%

1

%

3

%

2

%

0

%

6

%

Health Care

2

%

1

%

3

%

3

%

-2

%

6

%

Snacks and Pet Care

2

%

2

%

3

%

2

%

-1

%

6

%

Fabric Care and Home Care

0

%

0

%

2

%

5

%

-2

%

5

%

Baby Care and Family Care

 

1

%

 

1

%

 

 

2

%

 

5

%

 

 

1

%

 

9

%

Total Company

1

%

1

%

3

%

4

%

-2

%

6

%

 

Article source: Read More